Category Patenting living organisms

Dealing with intellectual property issues linked to affordability and access to medicines, included in the WHO Essential Medicines List (EML).

IP on basic research reduces subsequent scientific research and product development

Patent protection leads to decreased quality of diagnostics (in gene research)

Patent protection does not contribute to innovation (in gene research)

US Supreme Court: Can’t patent genes (Myriad case)

Space-resistant bacteria considered intellectual property of European Space Agency

Patents slow innovation – case study of human gene patenting by Celera

TPP seeks to allow patenting of medical *methods*